# NCT04395677 (NCT04395677)

> A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04395677
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Nuvation Bio Inc.
- Conditions: Non Small Cell Lung Cancer
- Interventions: AB-106
- Enrollment: 173
- Primary outcome: Best overall response (BOR) by IRC

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 2
- Bluesky threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct04395677